Volume 27, Number 9—September 2021
Dispatch
Bordetella hinzii Meningitis in Patient with History of Kidney Transplant, Virginia, USA
Joseph Pechacek
, Jillian Raybould, and Megan Morales
, Jillian Raybould, and Megan Morales
Table 2
Antibiotic susceptibility of Bordetella hinzii isolate from blood and cerebrospinal fluid in transplant patient, Virginia, USA*
| Antibiotic | Etest MIC from blood | Etest MIC from CSF |
|---|---|---|
| Ceftazidime | 4 μg/mL | 2 μg/mL |
| Ciprofloxacin | 2 μg/mL | 2 μg/mL |
| Imipenem | 2 μg/mL | 1 μg/mL |
| Meropenem | 0.125 μg/mL | 0.125 μg/mL |
| Piperacillin | 1 μg/mL | 1 μg/mL |
| Tobramycin | 8 μg/mL | 4 μg/mL |
| Trimethoprim/sulfamethoxazole | 0.125 μg/mL | 0.064 μg/mL |
*Etest, bioMérieux (https://www.biomerieux.com). CSF, cerebrospinal fluid.
Page created: July 11, 2021
Page updated: August 18, 2021
Page reviewed: August 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.